Cleared Traditional

K193061 - G3 40 Radiopaque Bone Cement

K193061 is an FDA 510(k) clearance for G3 40 Radiopaque Bone Cement, manufactured by G21, S.R.L.. The device is a Class 2 Orthopedic device with product code LOD cleared through the Traditional 510(k) pathway after a 139-day FDA review.

K193061 · G21, S.R.L. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2020
Decision
139d
Days
Class 2
Risk

K193061 is an FDA 510(k) clearance for the G3 40 Radiopaque Bone Cement. Classified as Bone Cement (product code LOD), Class II - Special Controls.

Submitted by G21, S.R.L. (San Possidonio, IT). The FDA issued a Cleared decision on March 19, 2020 after a review of 139 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3027 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all G21, S.R.L. devices

FDA 510(k) Submission Details - K193061

510(k) Number K193061 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 01, 2019
Decision Date March 19, 2020
Days to Decision 139 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
17d slower than avg
Panel avg: 122d · This submission: 139d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LOD Device Classification - Class 2, Special Controls

Product Code LOD Bone Cement
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3027
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

RQMIS, Inc.
Barry E Sands

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LOD Bone Cement

All 52
Devices cleared under the same product code (LOD) and FDA review panel - the closest regulatory comparables to K193061.
BonOs HV Genta, BonOs MV Genta, BonOs LV Genta
K210125 · Osartis GmbH · Mar 2021
PALACOS R, PALACOS R pro, PALACOS R+G, PALACOS R+G pro, PALACOS MV+G
K202475 · Heraeus Medical GmbH · Nov 2020
G1 40 Radiopaque Bone Cement
K193059 · G21, S.R.L. · Mar 2020
Hi-Fatigue Bone Cement
K192394 · Osartis GmbH · Dec 2019
Hi-Fatigue G Bone Cement
K192379 · Osartis GmbH · Nov 2019
PALACOS fast R+G
K190766 · Heraeus Medical GmbH · May 2019